Mimedx PE ratio MDXG

Share price divided by earnings per share over the last twelve months, since 2015.

Today, Oct 23, 2026: 97.8×
10-year median: 21.1×
Against its 10-year history: 92nd; percentile: 0 is its lowest day, 100 its highest
10-year range: 3.7× to 119×
Peer median: 26.6×

Mimedx's PE ratio is 97.8× as of Oct 23, 2026: a share price of $3.91 against $0.04 of earnings per share over the last twelve months.

That is above its ten-year median of 21.1×, higher than on 92% of days in the last ten years.

Over that time it ranged from 3.7× in Dec 2018 to 119× in Sep 2026.

The median for 10 medical instruments and supplies stocks of a similar size is 26.6×.

PE ratio over time

median 21.1×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	97.8×	10.7×	119×
2025	25.6×	16.6×	34.8×
2024	19.6×	9.1×	22.1×
2023	n/m a value too high to mean anything
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	16.6×	16.6×	24.3×
2019	23.4×	6.6×	23.9×
2018	4.8×	3.7×	55.5×
2017	40.7×	35.8×	115×
2016	52.1×	27.3×	58.6×
2015	52.1×	43.1×	218×

Against its peers

Companies in Medical - Instruments & Supplies nearest Mimedx's size, closest first, today.

Company	PE ratio
MDXGMimedx	97.8×
TCMDTactile Systems Technology	21.9×
MOVMovado	17.5×
EMBCEmbecta	4.6×
IRMDIradimed	47.9×
STAAStaar Surgical	323×
INFUInfuSystem	34.0×
BVSBioventus	19.4×
CDRECadre	37.0×
UTMDUtah Medical Products	22.6×
EYENational Vision	30.6×
Peer median	26.6×

Where Mimedx ranks

#33of 35Medical instruments and supplies stocks with the lowest PE ratio

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Mimedx

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.